US Stock MarketDetailed Quotes

ENLV Enlivex Therapeutics

Watchlist
  • 1.300
  • 0.0000.00%
Close Dec 4 16:00 ET
  • 1.300
  • 0.0000.00%
Post 20:02 ET
28.59MMarket Cap-1326P/E (TTM)

Enlivex Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
51.88%-2.62M
74.41%-1.8M
22.03%-4.51M
1.80%-23.52M
-9.53%-5.28M
17.50%-5.44M
24.26%-7.02M
-76.93%-5.78M
-36.55%-23.95M
26.90%-4.82M
Net income from continuing operations
56.36%-2.6M
54.42%-3.1M
42.64%-4.14M
6.41%-29.07M
-26.51%-9.1M
-4.01%-5.96M
31.48%-6.79M
12.24%-7.22M
-114.68%-31.06M
-51.79%-7.19M
Operating gains losses
719.61%836K
-58.12%98K
-105.53%-77K
-118.31%-363K
-52,175.00%-2.09M
103.52%102K
-91.99%234K
-29.20%1.39M
135.47%1.98M
99.88%-4K
Depreciation and amortization
-24.77%161K
-24.53%160K
-10.05%188K
7.46%835K
-9.50%200K
11.46%214K
20.45%212K
11.17%209K
42.31%777K
47.33%221K
Other non cash items
-50.00%108K
-63.27%83K
-52.88%98K
494.46%4.94M
1,982.52%4.29M
0.93%216K
0.00%226K
12.43%208K
101.21%831K
-5.94%206K
Change In working capital
-260.72%-1.5M
140.31%570K
4.56%-962K
-326.12%-1.82M
-14.44%1.02M
-135.68%-415K
58.15%-1.41M
-155.11%-1.01M
159.25%804K
320.15%1.19M
-Change in prepaid assets
-363.69%-1.36M
317.40%1.44M
-27.85%355K
118.71%608K
154.13%262K
-46.74%515K
47.66%-661K
-53.50%492K
122.26%278K
24.14%-484K
-Change in payables and accrued expense
91.27%-60K
-69.78%-764K
-2.88%-1.21M
-179.43%-1.47M
-59.24%845K
-331.31%-687K
69.30%-450K
-224.37%-1.18M
7,816.67%1.85M
6,587.10%2.07M
-Change in other current liabilities
67.49%-79K
66.01%-103K
67.60%-104K
27.98%-955K
77.89%-88K
-140.59%-243K
53.38%-303K
-81.36%-321K
-1,478.57%-1.33M
-703.03%-398K
Cash from discontinued investing activities
Operating cash flow
51.88%-2.62M
74.41%-1.8M
22.03%-4.51M
1.80%-23.52M
-9.53%-5.28M
17.50%-5.44M
24.26%-7.02M
-76.93%-5.78M
-36.55%-23.95M
26.90%-4.82M
Investing cash flow
Cash flow from continuing investing activities
-64.59%1.4M
70.61%-794K
116.26%5.1M
-141.53%-25.97M
243.78%4.14M
-91.04%3.95M
92.95%-2.7M
-152.53%-31.35M
262.79%62.52M
46.20%-2.88M
Net PPE purchase and sale
89.66%-3K
-136.36%-16K
179.01%128K
98.73%-103K
101.70%44K
97.56%-29K
101.29%44K
82.98%-162K
-399.82%-8.12M
-149.85%-2.58M
Net investment purchase and sale
-109.21%-366K
71.63%-779K
115.77%4.92M
-136.61%-25.87M
1,486.78%4.09M
-91.21%3.97M
92.14%-2.75M
-151.44%-31.18M
292.06%70.65M
93.16%-295K
Net other investing changes
--1.77M
--1K
--53K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
-64.59%1.4M
70.61%-794K
116.26%5.1M
-141.53%-25.97M
243.78%4.14M
-91.04%3.95M
92.95%-2.7M
-152.53%-31.35M
262.79%62.52M
46.20%-2.88M
Financing cash flow
Cash flow from continuing financing activities
250K
10,421.43%4.42M
64.78%524K
140.00%360K
0
0
-16.00%42K
536.00%318K
-99.75%150K
0
Net common stock issuance
--250K
10,421.43%4.42M
64.78%524K
--360K
--0
--0
--42K
--318K
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--0
--0
--0
--0
-98.08%150K
--0
Cash from discontinued financing activities
Financing cash flow
--250K
10,421.43%4.42M
64.78%524K
140.00%360K
--0
--0
-16.00%42K
536.00%318K
-99.75%150K
--0
Net cash flow
Beginning cash position
7.87%4.17M
-82.74%2.34M
-97.57%1.23M
332.77%50.36M
-95.92%2.37M
-81.21%3.86M
-80.11%13.55M
332.77%50.36M
65.94%11.64M
148.86%58.05M
Current changes in cash
35.07%-970K
118.88%1.83M
103.02%1.11M
-226.88%-49.13M
85.16%-1.14M
-103.98%-1.49M
79.63%-9.68M
-165.21%-36.81M
669.50%38.72M
35.56%-7.69M
Effect of exchange rate changes
----
----
----
--0
----
----
----
----
--0
----
End cash Position
34.97%3.2M
7.87%4.17M
-82.74%2.34M
-97.57%1.23M
-97.57%1.23M
-95.92%2.37M
-81.21%3.86M
-80.11%13.55M
332.77%50.36M
332.77%50.36M
Free cash flow
51.98%-2.63M
74.32%-1.81M
23.43%-4.55M
25.93%-23.76M
28.58%-5.28M
29.74%-5.47M
44.28%-7.06M
-40.87%-5.95M
-67.34%-32.08M
2.95%-7.4M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 51.88%-2.62M74.41%-1.8M22.03%-4.51M1.80%-23.52M-9.53%-5.28M17.50%-5.44M24.26%-7.02M-76.93%-5.78M-36.55%-23.95M26.90%-4.82M
Net income from continuing operations 56.36%-2.6M54.42%-3.1M42.64%-4.14M6.41%-29.07M-26.51%-9.1M-4.01%-5.96M31.48%-6.79M12.24%-7.22M-114.68%-31.06M-51.79%-7.19M
Operating gains losses 719.61%836K-58.12%98K-105.53%-77K-118.31%-363K-52,175.00%-2.09M103.52%102K-91.99%234K-29.20%1.39M135.47%1.98M99.88%-4K
Depreciation and amortization -24.77%161K-24.53%160K-10.05%188K7.46%835K-9.50%200K11.46%214K20.45%212K11.17%209K42.31%777K47.33%221K
Other non cash items -50.00%108K-63.27%83K-52.88%98K494.46%4.94M1,982.52%4.29M0.93%216K0.00%226K12.43%208K101.21%831K-5.94%206K
Change In working capital -260.72%-1.5M140.31%570K4.56%-962K-326.12%-1.82M-14.44%1.02M-135.68%-415K58.15%-1.41M-155.11%-1.01M159.25%804K320.15%1.19M
-Change in prepaid assets -363.69%-1.36M317.40%1.44M-27.85%355K118.71%608K154.13%262K-46.74%515K47.66%-661K-53.50%492K122.26%278K24.14%-484K
-Change in payables and accrued expense 91.27%-60K-69.78%-764K-2.88%-1.21M-179.43%-1.47M-59.24%845K-331.31%-687K69.30%-450K-224.37%-1.18M7,816.67%1.85M6,587.10%2.07M
-Change in other current liabilities 67.49%-79K66.01%-103K67.60%-104K27.98%-955K77.89%-88K-140.59%-243K53.38%-303K-81.36%-321K-1,478.57%-1.33M-703.03%-398K
Cash from discontinued investing activities
Operating cash flow 51.88%-2.62M74.41%-1.8M22.03%-4.51M1.80%-23.52M-9.53%-5.28M17.50%-5.44M24.26%-7.02M-76.93%-5.78M-36.55%-23.95M26.90%-4.82M
Investing cash flow
Cash flow from continuing investing activities -64.59%1.4M70.61%-794K116.26%5.1M-141.53%-25.97M243.78%4.14M-91.04%3.95M92.95%-2.7M-152.53%-31.35M262.79%62.52M46.20%-2.88M
Net PPE purchase and sale 89.66%-3K-136.36%-16K179.01%128K98.73%-103K101.70%44K97.56%-29K101.29%44K82.98%-162K-399.82%-8.12M-149.85%-2.58M
Net investment purchase and sale -109.21%-366K71.63%-779K115.77%4.92M-136.61%-25.87M1,486.78%4.09M-91.21%3.97M92.14%-2.75M-151.44%-31.18M292.06%70.65M93.16%-295K
Net other investing changes --1.77M--1K--53K----------------------------
Cash from discontinued investing activities
Investing cash flow -64.59%1.4M70.61%-794K116.26%5.1M-141.53%-25.97M243.78%4.14M-91.04%3.95M92.95%-2.7M-152.53%-31.35M262.79%62.52M46.20%-2.88M
Financing cash flow
Cash flow from continuing financing activities 250K10,421.43%4.42M64.78%524K140.00%360K00-16.00%42K536.00%318K-99.75%150K0
Net common stock issuance --250K10,421.43%4.42M64.78%524K--360K--0--0--42K--318K--0--0
Proceeds from stock option exercised by employees --0--0--0--0--0--0--0--0-98.08%150K--0
Cash from discontinued financing activities
Financing cash flow --250K10,421.43%4.42M64.78%524K140.00%360K--0--0-16.00%42K536.00%318K-99.75%150K--0
Net cash flow
Beginning cash position 7.87%4.17M-82.74%2.34M-97.57%1.23M332.77%50.36M-95.92%2.37M-81.21%3.86M-80.11%13.55M332.77%50.36M65.94%11.64M148.86%58.05M
Current changes in cash 35.07%-970K118.88%1.83M103.02%1.11M-226.88%-49.13M85.16%-1.14M-103.98%-1.49M79.63%-9.68M-165.21%-36.81M669.50%38.72M35.56%-7.69M
Effect of exchange rate changes --------------0------------------0----
End cash Position 34.97%3.2M7.87%4.17M-82.74%2.34M-97.57%1.23M-97.57%1.23M-95.92%2.37M-81.21%3.86M-80.11%13.55M332.77%50.36M332.77%50.36M
Free cash flow 51.98%-2.63M74.32%-1.81M23.43%-4.55M25.93%-23.76M28.58%-5.28M29.74%-5.47M44.28%-7.06M-40.87%-5.95M-67.34%-32.08M2.95%-7.4M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data